CTOs on the Move

Global Research Services

www.grs-cro.com

 
Global Research Services is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.grs-cro.com
  • 2101 Gaither Rd Ste 450
    Rockville, MD USA 20850
  • Phone: 301.424.9700

Executives

Name Title Contact Details

Similar Companies

CoreLab Partners

CoreLab Partners is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bradford Health Services

Its never easy to admit that you or someone you care about is addicted to alcohol or drugs. But once you recognize the problem, the road to recovery appears at your feet. The first step down that road is to find professional help.

Skinvisible Pharmaceuticals

Skinvisible Pharmaceuticals is a Las Vegas, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

automation X

automation X is a Vienna, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tanner Pharma

For over 18 years, Tanner Pharma Group has provided highly specialized pharmaceutical services to its partners around the world. Leading pharmaceutical and biotech companies partner with Tanner Pharma to license and commercialize their products in challenging international markets, develop and manage their Global Access Programmes, and source comparator drugs for clinical trials and bioanalysis. By partnering with Tanner Pharma, manufacturers are able to focus on their primary markets and strategies while ensuring that the services they need will follow a strictly controlled protocol of quality. Headquartered in the U.S. with offices in London, São Paulo and Mexico City, Tanner Pharma Group`s reach includes Europe, Asia, the Middle East, Australia, Canada and Latin America. We measure our value as a company based on the lives we help to improve. For all of us involved in the pharmaceutical supply chain - manufacturers, distributors, pharmacists, doctors, and others - it is ultimately the patient that matters most. Therefore, we start each day with a renewed commitment to ethically supply unlicensed medicines to markets where access continues being a challenge.